Vachhani Pankit, Mendler Jason H, Evans Andrew, Deeb George, Starostik Petr, Wallace Paul K, Wang Eunice S
Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Case Rep Hematol. 2016;2016:1259759. doi: 10.1155/2016/1259759. Epub 2016 Dec 29.
Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by internal tandem duplication ( ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of ITD mutant AML in the literature. Our patient was an elderly woman with relapsed and ITD mutant AML whose disease underwent SR for a brief duration without precipitating cause. We review the potential immune mechanisms underlying SR in AML and discuss the implications for novel immunotherapeutic approaches for mutant AML.
急性髓系白血病(AML)的自发缓解(SR)是一种非常罕见的现象。以内部串联重复(ITD)为特征的AML通常与侵袭性临床病程相关,在没有进行移植的情况下,疾病进展迅速、易复发且总生存期短。我们在此报告文献中首例ITD突变型AML自发缓解的病例。我们的患者是一名老年女性,患有复发的ITD突变型AML,其疾病在无明显诱因的情况下短暂出现自发缓解。我们回顾了AML自发缓解潜在的免疫机制,并讨论了其对突变型AML新型免疫治疗方法的启示。